Direct Biologics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Direct Biologics

Access the complete profile.

Direct Biologics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325414 Biological Product Manufacturing
Address	6070 Telegraph Rd Saint Louis, MO 63129

Note: Revenues for privately held companies are statistical evaluations.


Direct Biologics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Direct Biologics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Direct Biologics is classified as operating in the Biological Product Manufacturing industry, NAICS Code 325414.

Direct Biologics Annual Revenue and Growth Rate

Direct Biologics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Direct Biologics's revenues are gauged from an analysis of company filings.

Direct Biologics's Income Statement (based on Industry Averages)

Direct Biologics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Direct Biologics is developing and marketing. Direct Biologics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EVZULY Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.	01/16/2024
SIGMIVY Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.	01/16/2024
ZYGFLOVI Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.	01/16/2024

See all trademarks and details in the Full Report.

Market Share of Direct Biologics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Direct Biologics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
OXFORD BIOMEDICA SOLUTIONS	Bedford, MA	100
LAMPIRE BIOLOGICAL LABS	Pipersville, PA	85
MG BIOLOGICS	Ames, IA	39
BIO-SYNTHESIS	Lewisville, TX	37
GREEN MOUNTAIN ANTIBODIES	Burlington, VT	34
TRANS-INDIA PRODUCTS	Santa Rosa, CA	28
PMA MEDIA GROUP	Lehi, UT	25
BAILEY BARK MATERIALS	Nacogdoches, TX	24
1GLOBE HEALTH INSTITUTE	Norwood, MA	23

Nearby Competitors

These companies are similar in business line and location to Direct Biologics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BAYER CORPORATION C/O HR OPERATIONS DEPARTMENT	St. Louis, MO	100
MEDCO HEALTH SOLUTIONS	St. Louis, MO	18
VI-JON	St. Louis, MO	6
CURIUM US	Maryland Heights, MO	3
NOMAX	St Louis, MO	1
PARTICLE DYNAMICS INTERNATIONAL	St Louis, MO	0

Future Competition: Direct Biologics's Fastest Growing Competitors

These companies are in the same general field as Direct Biologics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)